Maritime Pine

Contentus

• Potest enim effective ...
• Potest enim vis ulla ...
• Effectiveness rate ut quod est insufficiens ...
• & Cautiones admonitio specialis;

Nec nautica pinus mutabit arbores crescere in terris mare magnum in mare. Et ut valentes latrare videntes vana medicina adhibetur. Nec nautica pinus mutabit quae nascuntur in spatio et in meridiem Gallia sunt ad Pycnogenol, commercium available in US descripserunt tincidunt nec nautica pinus mutabit valentes latrare videntes vana nomen extract.

Nec nautica pinus mutabit extract valentes latrare videntes vana est propter suspiriosis et improvidus athletice perficientur, potest facere ex pauper circulationem crura in tumorem convertendum (inveterata venarum insufficientiam vel CVI), et multis aliis condiciones, sed non limitantur est scientific indicio suscipere aliquid horum usus.

Naturalis conficiendi medicamenta Comprehensive Database rates fundatur super efficaciam scientific hoc quod ex scale: Effectiva, minime efficax, efficax Forsitan, Fortasse senserunt esse, minime Ineffective, Ineffective et Rate est quaedam feruntur.

Et efficaciam ratings nec nautica pinus mutabit ita se habet:

Potest enim effective ...

• suspiriosis. Pinei corticis extractum standardises quotidianum sumeret maritimi cum suspirio medicaminibus nonummy decrescere videntur signa salutis opus cum adultis liberis Inhalers suspirio. Ut memores sitis eorum, quae nec nautica pinus mutabit non valentes latrare videntes vana extract ut medicina usus est in locum anhelis.
• Curabitur aliquet euismod. Iuvenes (aetas 20-35 annos) videntur posse exercere diutius in a antliam condemnato ad a standardized extract ex tempore dato antea nec nautica pinus mutabit valentes latrare videntes vana cotidie pro circiter mensem. Item, physica idoneitatem, athletarum exercentes in test aut magis praestare videtur Quisque ornare probat in VIII weeks nam et certationis cum hoc extract cum cotidiana exercitatione.
• Qui autem pauper circulationem crura ad facere tumescat (inveterata venarum insufficientiam, aut cvi). Ergo vindicatio videtur esse standardized extract de ore nec nautica pinus mutabit per medullas robur corticemque videtur ad redigendum dolor et crus gravitatem, tum liquor retention et qui cum circulationem problems. Uti extract id est compressionem pedules et efficaciora esse videtur quam per compressionem pedules solus. Equum castaneis extractum est semen quoque nonnulli utuntur hac conditione tractare et uti extract nec nautica pinus mutabit valentes latrare videntes vana efficaciora esse videtur.

Potest enim vis ulla ...

• princeps cholesterol. Magis ostendit quod non de mensuris inferiorem pinei corticis extractum maritimis "Cura mali" (low densitate lipoprotein (LDL) eu) hominum eu magna.

Effectiveness rate ut quod est insufficiens ...

• Idque memoria declinare solet cogitandi artes aevo. Most research in sanus senes populi non invenies vel cogitandi artes memoria standardized extract a captis propioribus prodesse valentes latrare videntes vana est nec nautica pinus mutabit.
• Caecitatem arterias (ATHEROSCLEROSIS). Aliquod argumentum sumere de mensuris pinei corticis extractum maritimis quotidie ter IV weeks indurata per arterias inpedimenta iuvaret aliquam condimentum.
• Operam defectubus hyperactivity inordinatio, (ADHD). Ergo vindicatio videtur esse standardized extract de ore nec nautica pinus mutabit per medullas robur corticemque non videntur indicia ADHD in auxilium adultis. Sed indigne ferens filios per os unius mensis symptoms amplio videtur.
• A rara morbo involving gravibus ulceribus in ore atque alias corporis partes (Oralis syndrome). Standardized extract ex primo investigationes ostendit quod accipiens nec nautica pinus mutabit valentes latrare videntes vana et odoris melioris indicia sunt in populo Oralis syndrome.
• Dilatabitur prostate (benigna prostatic hyperplasia et BPH). Standardized extract ex primo investigationes deprehendi suo moram nec nautica pinus mutabit valentes latrare videntes vana est coniunctum melius facultatem ad MIO in populum BPH.
• Et cogitandi artes Memoria (cognitiva munus). Standardized extract ex primo investigationes deprehendi suo moram nec nautica pinus mutabit valentes latrare videntes vana, et memoriam per os improves mentis munus in adultis. Is quoque amplio vel nonnihil videtur test ustulo in collegium alumni.
• Declines in memoriam populi cogitandi artes maior, quod est in plus quam pro aetate quae sit normalis. Standardized extract ex primo investigationes ostendit quod accipiens nec nautica pinus mutabit improves valentes latrare videntes vana mentis munus in adultis remisso lumine mentis incom.
• commune frigus. Standardized extract ex primo investigationes deprehendi suo moram nec nautica pinus mutabit valentes latrare videntes vana ab ore incipiens bis cotidie in a frigus de initium videtur minuere numerum dierum et cum frigida. Etiam potest ad redigendum super-the-occurro moles frigus products opus ad curo docebo.
• dens TABULA. Primo quidem investigationis insinuat quod conterendum cibum VI pieces of additae gum et extract a ad XIV dies reducit sanguinem nec nautica pinus mutabit valentes latrare videntes vana et impedit TABULA auctus.
• DIABETES. Standardized extract a primis quod innuit moram nec nautica pinus mutabit valentes latrare videntes vana cotidie minuitur sanguis sugar pro 3-12 hebdomades cum ignominia in populum cum diabete.
• Pes ulcera in populum cum diabete. Mane investigationis insinuat quod si accipiatur nec nautica pinus mutabit valentes latrare videntes vana extract a cute ad os, ut applicent pede cura compellit, ulcera mortifera adjuvat ad diabete.
• A morbo est parva vasis sanguineis in populum cum diabete (Diabetic microangiopathy). Meat: mane investigationis ostendit quod nec nautica pinus mutabit standardized extract valentes latrare videntes vana ter cotidie ad IV weeks et symptoms amplio circulationem in populum cum diabete.
• Vision problems in populum cum diabete (diabetic retinopathy). Ergo vindicatio videtur esse standardized extract de ore nec nautica pinus mutabit per medullas robur corticemque II menses et amplius ne videtur slow vel pede morbo est crescente causa per diabete, ATHEROSCLEROSIS, vel morbo. Etiam videtur ut amplio visu.
• ore sicco. Standardized extract investigationis ostendit quod mane acceptis ab una ex artificialis nec nautica pinus mutabit valentes latrare videntes vana improves saliva saliva ore sicco magis quam artificialis solus.
• Praesent (ED). Standardized extract investigationis insinuat quod nec nautica pinus mutabit mane valentes latrare videntes vana, uti sola aut cumulative cum L-arginine, ut amplio sexualem munus apud homines, ED rectangulo. Ut videtur, ad III menses curatio ad a significant melius.
• Kessinger febricitantem. Quidam research ostendit quod accipiens maritimis pinei corticis extractum de mensuris urna ante initium temporis minuat urna betula symptoms cum allergies.
• haemorroidum. Standardized extract ex primo investigationes ostendit quod accipiens nec nautica pinus mutabit per medullas robur corticemque ore, hoc eodem sola aut cumulative cum crepito extract continet, et indicia vitae improves qualis anorum. Alius research ostendit quod idem extract a sumptione huius sacramenti, potest emendare salubria haemorroidum sunt in os mulieribus post partum extitit.
• Princeps sanguinem pressura. Quidam research ostendit quod accipiens standardized extract de valentes latrare videntes vana nec nautica pinus mutabit potest elevare sanguinem pressura. Sed effectus non alii research docuit.
• A diu-terminus per inordinationem magno termini bene facit ad stomachum dolor intestinis (iracundior alvus syndrome vel IBS). Standardized extract ex primo investigationes suo moram facit deprehendi potest reducere abdominis dolor nec nautica pinus mutabit valentes latrare videntes vana, cramps, medicamento usus in populo, et ex IBS.
• Jet TARDO. Standardized extract ex primo investigationes deprehendi suo moram nec nautica pinus mutabit valentes latrare videntes vana, 2-3 diebus ante incipiens a fuga planum, quod potest breviare tempus et etiam jet TARDO Signa fieri ad redigendum symptoms jet TARDO.
• crus cramps. Aliquod argumentum sumere de mensuris pinei corticis extractum oris maritimis quotidie minuerit crus cramps.
• Notatum esse inordinatio in aure interiore vertigine, damnum auditus, et resonant aure (Meniere morbus). Standardized extract ex primo investigationes ostendit quod accipiens nec nautica pinus mutabit non valentes latrare videntes vana, et sonant aures pauci numero adultorum est Meniere scriptor morbus symptoms in altiore.
• Salubria de menopause. Standardized extract ex primo investigationes deprehendi suo moram nec nautica pinus mutabit valentes latrare videntes vana decrementum Menopausalis symptoms ab oris, inter languor, capitis dolore, tristitia et cura et calidum fulguris.
• A copula symptoms auget periculum diabete, cor morbo et plaga (metabolicae syndrome). Mane investigationis insinuat quod accipiens standardized extract ex nautica pinus mutabit per medullas robur corticemque os ter cotidie pro VI mensibus dimittit, triglycerides, sanguinem sugar campester, et sanguis pressura et crescit summus densitate lipoprotein ( "bona" ​​vel HDL) cholesterol in populum metabolicae syndrome .
• Poma (inflammatio) et factum est vulnus intra os (oris Mucositis). Applicando standardized extract a solution ex quibus nec nautica pinus mutabit valentes latrare videntes vana cura subsidium intra os ad os ulcera, una sabbatorum videtur in Pueros et adulescentes chemotherapy patiens curatio.
• Osteogenesis imperfecta. Est autem mixta quod circa efficaciam nec nautica pinus mutabit quia OSTEOARTHRITIS. Pinei corticis extractum oris maritimis accipiens standardises redigerent feugiat Signa autem videtur posse reduci ad meliorem cotidie dolor. Quae mane refert pittacia passim disposita in standardized extract a investigationis et invenerunt cumba nec nautica pinus mutabit ut cute ad redigendum dolor in populum apud OSTEOARTHRITIS de genu.
• Parkinson morbus. Standardized extract ex primo investigationes deprehendi suo moram nec nautica pinus mutabit valentes latrare videntes vana una cum levodopa / Lorem carbidopa improves tremor corporis et alia symptomata. Etiam videtur ut amplio mentis munus.
• Qui gravida mulieres in dolore. Standardized extract de mane investigationis insinuat quod moram nec nautica pinus mutabit per os cotidie in novissimo III menses graviditatis reduces inferioribus retro dolor, coxae iuncturam dolor, pelvis dolor et dolor Varices vel ex eis vitulum cramps.
• Intrapelvicorum dolorem in mulieribus. Standardized extract a mane est quod dicit quod si accipiatur de auxilio minuere nec nautica pinus mutabit valentes latrare videntes vana per os fortiter columnis feminae intrapelvicorum dolorem, cum endometriosis, vel in gravibus menstruo cramps.
• Squamea convolvens, SCABIOSUS cutis (PSORIASIS). Standardized extract ex primo investigationes deprehendi suo moram nec nautica pinus mutabit non valentes latrare videntes vana per os redigendum in mole et tabulae cutis, emendare qualitas vitae reduce et steroids in usum populus cum PSORIASIS.
• Qui mortem responsio ad maxime in frigida manuum ac pedum summitatibus (Raynaud syndrome). Standardized extract ex primo investigationes deprehendi suo moram nec nautica pinus mutabit valentes latrare videntes vana can amplio in frigore et dolore digitos in populo huic conditioni.
• Age-related musculus damnum (sarcopenia). Standardized extract ex primo investigationes deprehendi suo moram nec nautica pinus mutabit per medullas robur corticemque improves oris musculus munus in signa et senes de adultis musculus damnum.
• Autoimmune inordinatio quae est in eo glandulis producere saliva lacrimis laeduntur (Sjogren syndrome). In investigationis ad populum mane syndrome inventus Sjogren standardized extract id acciperet ab ore reduces per medullas robur corticemque nec nautica pinus mutabit signa oculum sicco ore et aridam. Etiam opus ad redigendum certus ut medicinis.
• Autoimmune morbus est quod causat magnam tumentes (systemic lupus erythematosus aut SLE). Standardized extract de mane investigationis insinuat quod moram nec nautica pinus mutabit signa per medullas robur corticemque os reduces SLE in aliquibus aegris.
• Resonant aures (tinnitus). Standardized extract investigationis insinuat quod primo accipit nec nautica pinus mutabit valentes latrare videntes vana reduces de tinnitu aurium.
• Varices. Standardized extract ex primo investigationes ostendit quod accipiens nec nautica pinus mutabit non valentes latrare videntes vana redigendum crus cramps, crus tumor, et numerum Varices aráneam venis atque in mulieribus post partum extitit.
• Formet, ut in venis sanguis clots (sive venarum thromboembolism VTE). Corticis extractum tantum accipere prius et posterius specie longis nautica pinus mutabit videtur coit in sanguinem populum ne periculo. Sed post redigeret periculo thrombotic syndrome. Haec conditio iam non develop qui erant in sanguinem concretum remansisse.
• Cor defectum.
• musculus soreness.
• Problems per sexualem munus.
• plaga praeventionis.
• aliis conditionibus.

Necesse est ut nec nautica pinus mutabit rate magis quod propter illos usus.

Nec nautica pinus mutabit continet substantias ut amplio cruor flow. Ut stimulate et in immune ratio, reducere tumor, ne infectiones, et habet antioxidant effectus.

Cum sublatus ab oris: A standardized extract ex nautica pinus mutabit valentes latrare videntes vana (Pycnogenol, Horphag Research) est, POTEST FIERI ARMARIUM bibitur usque 50-450 mg per singulos annos. Non potest vertigine, stomachum problems, capitis dolores, ulcera oris et spiritus malus.

Cum applicantur ad cutem: A standardized extract ex nautica pinus mutabit valentes latrare videntes vana (Pycnogenol, Horphag Research) est, POTEST FIERI ARMARIUM sicut pro crepito usque ad VII dies VI weeks vel sicut pulveris ad usque.

& Cautiones admonitio specialis;

Graviditate ac loricam pascens: De standardized extract a ad investigationis insinuat quod nec nautica pinus mutabit valentes latrare videntes vana (Pycnogenol, Horphag Research) est, POTEST FIERI ARMARIUM Cum nuper in graviditate. Autem, est magis nota prius, oportet illud esse temperate, vel fugiendum gravida mulieres qui.

Est non satis certa notitia de salute nec nautica pinus mutabit products, si sumendi sunt pectus pascens. Tuto manere, ne usu.

liberi: A standardized extract ex nautica pinus mutabit valentes latrare videntes vana (Pycnogenol, Horphag Research) est, POTEST FIERI ARMARIUM Cum sublatus ab ore, brevis-term.

"Auto-morbo tutum" ut multiplex MEMORIOLA (MS) lupus (systemic lupus erythematosus interfice), rheumatoid arthritis (RA), vel aliis conditionibus, Nec nautica pinus mutabit ut faciam in immune ratio ad active plures facti sunt: ​​non crescat, et hoc morbo salubria de auto-immune. Quod si vos habere unum ex his rebus, est optimum ad vitare usura nec nautica pinus mutabit ..

sanguinem conditionibus, In doctrina, nec nautica pinus mutabit altum gustatu de periculo ut proventus populus in sanguinem et sanguinem conditionibus.

DIABETES, In doctrina, nec nautica pinus mutabit altum gustatu de minuerit sanguis sugar nimis in populum cum diabete.

Hepatitis, In doctrina, nec nautica pinus mutabit taking ut peior fieri potest iecoris munus et Hepatitis in populo.

surgery: Slow nec nautica pinus mutabit ne sanguinem clotting, et sanguis sugar minuere. Est aliqua de causa sanguinem saccharo ut ne quod forte multiplicentur nimis humilis et inter sanguinem et post surgery. Nec nautica pinus mutabit prohibere usura a scheduled saltem II weeks ante surgery.

moderatus

Videte, hoc compositum.

Rememdium pro diabete (Antidiabetes medicinae VI)

Nec nautica pinus mutabit minuerit sanguinem sugar campester. Etiam placerat medicamenta ad elevare sanguinem saccharo. Consecraret accipiens sanguinem saccharo medicamenta placerat nautica pinus simul ad inferius. Monitor sanguinem saccharo propinqua. In dose of vestri diabetes postulo ut elit sit mutata.

Quidam medications diabete includit glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, micronase), insulin, pioglitazone (Diazepam), rosiglitazone (Avandia), et aliis. In mechanism de actio est lateat.

Medicamentum pauci numero, qui in immune ratio (Immunosuppressants)

Nec nautica pinus mutabit videtur crescat in immune ratio. Per augendae immune ratio, nec nautica pinus mutabit medicamentum ex minuerit ad efficaciam, quae decrescunt in immune ratio.

Quidam medications, qui pauci numero feugiat nulla includit Tacrolimus (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab, CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, prograf ), Sirolimus (Rapamune) valium (deltasone, Orasone), corticosteroids (glucocorticoids), et aliis.

Medicamentum tardi sanguinem clotting (Anticoagulant / Antiplatelet medicinae VI)

Nec nautica pinus tarda vires sanguis concretionis. Nec nautica pinus mutabit accipiens medications ut per patientiam et continens concretionis, ut augere chances illa de conterendo et sanguinem.

Quidam medications qui patiens clotting sanguinis includit aspirin clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), warfarin (Coumadin), et aliis.

Herbarum Supplementa esset inferior sanguis sugar

Nec nautica pinus mutabit ut elevare sanguinem GLYCOSA campester. Uti herbis aliis causis effectus Supplementa eodemque stillabunt humilis sanguinem sugar campester. Quidam supplements ut herbis et dulcis alpha-lipoic Acidum includere potest elevare sanguinem saccharo, interdum, pede diaboli est, et foenum Graecum et allium, guar gum, equus castaneis, Panax ginseng Psyllium psyllium, Siberian Ginseng et aliis.

Concretione sanguis tardius esset herbarum Supplementa

Uti herbis nec nautica pinus mutabit per sanguinem clotting slow qui poterant ad augendam periculo aliqui in sanguinem. Haec includit herbis angelica subita tumuit, danshen, allium, gingiberi, ginkgo: Panax ginseng et aliis.

Sunt non nota interactiones adsumat.

Et hoc genus institutorum continentur in portione medicatur altius sunt investigatae;

PUBERES

Per os:

• suspiriosis: I mg de valentes latrare videntes vana est standardized extract nec nautica pinus mutabit per libram corpus pondus, usque ad maximum a CC mg / die, data est in duas divisa doses pro mensis. Item, idem L mg de extract bis cotidie utendum est ad VI mensibus.
• Curabitur aliquet euismod, 100-200 mg a standardized extract nec nautica pinus mutabit valentes latrare videntes vana est usus cotidie pro 1-2 mensibus.
• Qui autem pauper circulationem crura ad facere tumescat (inveterata venarum insufficientiam, aut cvi): 45-360 mg per nec nautica pinus mutabit valentes latrare videntes vana standardized extract capta est tribus divisa doses usque ad 3-12 hebdomades cotidie per.

LIBERI

Per os:

• suspiriosis: I mg de standardized extract nec nautica pinus mutabit valentes latrare videntes vana est in duas divisa per libram corpus pondus est sumptus ad III menses paulatim per aetatis adolescentes et filii 6-18 annis.

Condensatione Tannins, Angiospermae de Pin, Angiospermae de Pin maritimis, Extrait d'Angiospermae de Pin, Galli Marine Pinus Fruit Extract, Gallica Maritime Pine Fruit Extract, Leucoanthocyanidins, Maritime Fruit Extract, Oligomères de Procyanidine, Oligomères Procyanidoliques, oligomeric proanthocyanidins, OPC, OPCs , PCO, p cos, pinei corticis conteritur, Kiefer Fruit Extract, pinaster Picea, Pinus maritima, Proanthocyanidines Oligomériques, Procyanidin oligomers, Procyanodolic oligomers, Pycnogenol, Pycnogénol, Pygenol, postea densatur Tannins.

Ut plures nuntios circa quam est articulus est scriptum, placet videre Naturalis conficiendi medicamenta Comprehensive Database methodorum sive inventarum.

1. Aldret duae RL, Bellar Geminus-A D. Si cæcum fuerit, edant carnes eorum Effectus Stude super Cross-Maritime Pine et extract a euismod Exercise postexercise Inflammatio, oxidative accentus: Musculus Soreness et damnum. Victu J v. MMXX: XVII: 309-20. View abstracto.
2. Cesarone MR, Belcaro G, Agus MB, et al. Et venarum microangiopathy inveterata venarum insufficientiam, per compressionem et Pycnogenol® administratione. Cardioangiol Minervae. MMXIX: LXVII, 280-7. View abstracto.
3. Hu S, M Hosoi, Belcaro G, et al. Management modo ex miti et prima Raynaud syndrome: suppletionem cum Pycnogenol®. Cardioangiol Minervae. MMXIX: LXVII, 392-8. View abstracto.
4. Cesarone MR, Belcaro G, M Hosoi, et al. Accessiones Pycnogenol® in administratione cum Parkinson scriptor morbus ne cognoscitiva incom. J Neurosurg ed. MMXX: LXIV: 258-62. View abstracto.
5. Vinciguerra G, Belcaro G, B Feragalli, et al. PycnoRacer®, bibere a comprehendo Pycnogenol® idoneitatem, melius et educatio in recuperatio Cooper test. Panminerva med MMXIX: LXI: 457-63. View abstracto.
6. Belcaro G, Cesarone MR, Cornelli U, et al. XEROSTOMIA: ne cum Pycnogenol® suppletionem, et gubernatori studium. Stomatol Minervae. MMXIX: LXVIII: 303-7. View abstracto.
7. Cesarone MR, Belcaro G, Scipione C, et al. Ne in perimenopausal feminarum vaginal siccitatem. ELOGIUM cum Prelox® domine. Ginecol Minervae. MMXIX; LXXI, 434-41. View abstracto.
8. Pourmasoumi M, Hadi A, B Mohammadi, Rouhani MH. Effectus in sanguine pressura de pycnogenol suppletionem: systematica analysis of meta-orci iudiciis et recensionem. Res Phytother. MMXX, XXXIV, 67-76. View abstracto.
9. Fogacci F, G Tocci, Sahebkar A: Presta V, M Banach: Cicero AFH. Pycnogenol effectus est super sanguinis pressionem: Inventiones a Review prisma Accommodatae Nomina Systematica et Meta-analysis Randomized, duplex caecus, placebo-sobrie, Fusce Studies. Angiológia. MMXX, LXXI, 217-25. View abstracto.
10. Smetanka A, V Stara, Farsky Ego sum Tonhajzerova, Ondrejka I. Pycnogenol suppletionem curatio est antidepressant adjunct-adductus est, sicut sexualem distemperantia. Int physiol. MMXIX: CVI: 59-69. View abstracto.
11. Luzzi R: Belcaro G, Hu S, et al. Efficacia Pycnogenol suppletionem remissionem relaxat, vertuntur species Sjogren syndrome. Cardioangiol Minervae. MMXVIII: LXVI, 543-546. DOI: 10,23736 / S0026-4725.18.04638-8. View abstracto.
12. A Sparke, Belcaro G, B Feragalli, et al. Benigna prostatic hypertrophy, Pycnogenol suppletionem amplio indicia et prostate vesicae RELICTUM volumine. Minerva Med. MMXVIII: CIX: 280-284. View abstracto.
13. Hu S: Belcaro G, A Sparke, et al. Oralis syndrome: essetenim procedere in effectis Pycnogenol suppletionem uti potest conditionibus. Cardioangiol Minervae. MMXVIII: LXVI: 386-390. View abstracto.
14. Hadi A, M Pourmasoumi, Mohammadi H, A Javaheri, Rouhani MH. Impulsum pycnogenol suppletionem super plasma lipids in homines: et recensionem systematica analysis of meta-orci iudiciis. Res Phytother. MMXIX: XXXIII: 276-287. View abstracto.
15. Feragalli B, Dugall M, R Luzzi, et al. Pycnogenol: adiecta est symptomatic administratione commissuram panni rudis in OSTEOARTHRITIS. Subcriptio cum observational studendum. Endocrinol Minervae. MMXIX: XLIV: 97-101. View abstracto.
16. Belcaro G, M Dugall Hu S, et al. Ne recurrentes ex venarum thrombosis et post-thrombotic syndrome. Cardioangiol Minervae. MMXVIII: LXVI: 238-245. View abstracto.
17. Belcaro G, Cornelli U, Dugall, M, Hosoi M, R Cotllese, Feragalli B. Long-bolum volatus, OEDEMA, et thrombotic certe, ne in laneis et suppletionem Pycnogenol (Latin LONFLIT Subcriptio). Ommovendo Cardioangiologica. Apr MMXVIII: LXVI: 152-9. View abstracto.
18. Ezzikouri S, T Nisimura, Kohara M, et al. Hepatitis C in effectis inhibitor Pycnogenol virus replicationem. Herpesvirus hominis Res. Ian MMXV; CXIII, 93-102. View abstracto.
19. Belcaro G, R Luzzi Hu S, et al. Melius in signa et symptoms in aegris cum PSORIASIS Pycnogenol suppletionem. Panminerva Med. Mar MMXIV, LVI: 41-8. View abstracto.
20. Belcaro G, Gizzi G, L Pellegrini, et al. In postpartum Pycnogenol symptomatic anorum. Ginecol Minervae. Feb MMXIV: LXVI: 77-84. View abstracto.
21. Belcaro G, M Dugall, Hosol M, et al. Et ad asymptomatic ATHEROSCLEROSIS progressum Pycnogenol Centella asiatica. Angiol Int. Feb MMXIV: XXXIII: 20-6. View abstracto.
22. Ikuyama S, B Fan ad annum J, K Mukae, Watanabe H. M. mechanism de intracellular lipidorum cumulus: suppressive Pycnogenol effectus est in iecoris cellulis. Eget Victus & In Salutem et Morbus CCIII, III: 353-364.
23. Luzzi R: Belcaro G, Hu S, et al. Et cochleae in emendationem symptoms fluxus Pycnogenol cum aegris cum morbo est Meniere et tinnitus. Minerva Med. Iun MMXIV, CV, 245-54. View abstracto.
24. Belcaro G, R Cesarone, Steigerwalt J; et al. -Jet TARDO: ne cum Pycnogenol. Primae famam: et iudicium hominum in hypertensive sanus aegris. Cardioangiol Minervae. Oct MMVIII, LVI (Suppl V) 3-9. View abstracto.
25. Matsumori A, B Higuchi, Gallica nec nautica pinus mutabit Shimada M. valentes latrare videntes vana extract inhibits virales replicationem et prohibet progressionem de virales MYOCARDITIS. J Fail Card. Nov MMVII, XIII, 785-91. View abstracto.
26. Belcaro G, R Luzzi, Dugall M, Ippolito E, Saggino A. Pycnogenol amplio cognitiva munus sit attenta, propria mentis perficientur et professio artes sana in doctorum aetatis 35-55. J Neurosurg ed. Dec MMXIV: LVIII: 239-48. View abstracto.
27. Sarikaki V, M Ralles, Tanojo S, et al. Herpesvirus hominis percutaneous effusio pinei corticis conteritur extract (Pycnogenol) in humani pellis. J Toxicol MMIV: XXIII: 149-158.
28. Luzzi R: Belcaro G, M Hosoi, et al. Menopausalis mulieres ordinationem cardiovascular periculo factores pre Pycnogenol. Ginecol Minervae. Feb MMXVII, LXIX: 29-34. View abstracto.
29. Valls RM, Llaurado E, Castellae Fernandez-S, et al. Hypothetica pondus est humilis dives effectus procyanidin extract a Gallica valentes latrare videntes vana et maritimam in periculo cardiovascular morbus factors in scaena I-hypertensive nostrorum: randomized, geminus-cæcus, crossover, placebo-sobrie iudicium interveniret. Phytomedicine. MMXVI Nov XV, XXIII, 1451-61. View abstracto.
30. Hosoi M, G Belcaro, Saggino A, Luzzi R, M Dugall, Feragalli B. Pycnogenol suppletionem minimam cognitiva distemperantia. J Nuerosurg ed. Iun MMXVIII: LXII: 279-284. View abstracto.
31. Belcaro G, M Dugall, Ippolito E, Hus S: Saggino A, et B. Feragalli COFU3 Study. In cognitiva munus melius, operam, est mentis perficientur in sanus subditis Pycnogenol (55-70) sunt altitudinis oxidative accentus. Dec J Neurosurg Sci MMXV, LIX, 437-46.
32. Belcaro G C. conservatio Dugall musculorum robur aetatis rebus Pycnogenol suppletionem massa. Minerva Ortopedica e Traumatologica MMXVI Israel: LXVII, 124-30.
33. Belcaro G, Dugall M, R Luzzi, Ippolito E, recta MR Cesarone. Postpartum Varices: A suppletionem cum XII-mensis-compresso elastica pycnogenol vel consequuntur, sunt. Int J Angiol. Mar MMXVII: XXVI, 12-19. View abstracto.
34. Belcaro G, Gizzi G, L Pellegrini, et al. Iracundior alvus syndrome imperium Pycnogenol suppletionem amplio indicia. Panminerva Med. Iun MMXVIII: LX: 65-89. View abstracto.
35. Belcaro orci comparationis A G. de pycnogenol, Antistax et inveterata venarum insufficientiam in metus. Int J Angiol. Dec MMXV: XXIV: 268-74. Iul 15 Epub MMXV View abstracto.
36. Taxon: Genus Pinus pinaster Aiton. Americae Eukaryota Regnum: Plantae Spermatophyta Ratio. Available at: https://npgsweb.ars-grin.gov/gringlobal/taxonomydetail.aspx?28525. Accessed May XXIX: MMXVIII.
37. Vinciguerra G, Belcaro G, E Bonanni, et al. Ab effectis ad iudicium suppletionem cum Pycnogenol in idoneitatem et normalis furens ira cum Exercitus Physical Opportunitas Test, et operas de athletae in in C-minute Quisque ornare. Quisque MMXIII IV Physic J Sports Med: LIII: 644-54. View abstracto.
38. A. Sahebkar systematica analysis of meta-recensionem et effectis pycnogenol super plasma lipids. Ibi J Cardiovasc Pharmacol MMXIV: XIX: 244-55. View abstracto.
39. Khurana n, Thomas Pandey, Saksena AK, Saint A. An iudicium et Vitaminum E in pycnogenol filii passus a cancer per oris Mucositis chemotherapy. De Dis Romanorum oris MMXIII: XIX: 456-64.View abstracto.
40. Bottari A: G Belcaro: A Sparke, et al. Domine Prelox improves potestatis sexualis usus in feminis plerumque sanus generatiua aetate. Minerva Ginecol MMXIII: LXV: 435-44. View abstracto.
41. Belcaro G, Shu H, R Luzzi, et al. Commune frigus Pycnogenol emendationem: hibernus subcriptio perspiciantur. Panminerva med MMXIV, LVI, 301-8. View abstracto.
42. Belcaro G, M Dugall, Luzzi R, M Hosoi, Corsi M. Aliquam venarum pycnogenol in sono cum inveterata venarum insufficientiam: an ex vivo studio & venae in segmentis. Int J Angiol MMXIV: XXIII: 47-52. View abstracto.
43. Belcaro G, Cornelli U, Luzzi R; et al. Pycnogenol suppletionem amplio valetudo periculo factores subditis metabolicae syndrome. Res Phytother MMXIII: XXVII: 1572-8.View abstracto.
44. Asmat U, Abad K, Ismail, et oxidative accentus, maxime summatim edicunt recensionem H. Diabete Mellitus. Saudi 2015 Available in tecta J: http://dx.doi.org/10.1016/j.jsps.2015.03.013.
45. Maritim in Arcanis Caelestibus, A. Sanders, William Watkins 3. Diabete, oxidative accentus et facilisis, nibh quis Vestibulum. J Mol Biol Toxicol MMIII: XVII: 24-38. View abstracto.
46. Farid R, Z Mirfeizi Mirheidari Rezaieyazdi Mansouri M Z, H H. Esmaelli Pycnogenol® reduces suppletionem amplio physica munus dolor et rigoremque in adultis OSTEOARTHRITIS de genu. NUTRICIUM Research MMVII, XXVII: 692-697.
47. Roseff SI, R. Gulati Emendationem sperma qualitas per pycnogenol. Eur tauri medicamentis Res MCMXCIX, VII, 33-36.
48. Durackova, B. Trebatický Novotny V. I. Žit®anová J. Breza. Et per lipidorum metabolismi erectile munus melius Pycnogenol®, extract de cortice gluten in aegris passus a Praesent Pinus pinaster - a gubernatori studium. NUTRICIUM Research MMIII: XXIII: 1189-1198.
49. Hosseini S, S Pishnamazi Sadrzadeh SMH Farid F Farid Watsoni R et RR. Pycnogenol in administratione anhelis. J MMI medicine cibum, IV: 201-209.
50. Durackova, Z., Trebaticky, B., Novotny, V.: Zitnanova: A. et Breza, J. lipidorum metabolismi et Pycnogenol Praesent a melius (R), Pinus pinaster extract de cortice gluten in aegris passus a Praesent - a gubernatori studium. Nutr.Res. MMIII: XXIII: 1189-1198.
51. T Kohama, Negami M. Effectus in low-dose Gallico Maritime Pine Fruit Extract Perimenopausal Women CLXX per quam climacteras appellant syndrome: a randomized, duplex caecus, placebo-sobrie iudicium. J generatiua med MMXIII, LVIII, 39-47.
52. Schmidtke Ego vereor condiscipulorum ne W. Pycnogenol: atque habitus medicinae curatio OEDEMA. Schweizerische Zeitschriftfur GanzheitsMedizin MCMXCV, III: 114-115.
53. Hosseini, S., Lee, J., Sepulveda, RT, Fagan: T. Rohdewald, P., and mi Watson, R A randomized, duplex caecus, placebo sobrie et futurum XVI septem partes crossover studium ad determinare Pycnogenol (R ) per initia moderatus est, cum inflexo sanguinem pressura in hypertensive aegros. Nutr.Res. MMI: XXI: 67-76.
54. S Wang, Zhao D N Tan et al. Quod autem effectus in pycnogenol microcirculation, platelet et ischemic myocardium munus in patientibus coronarius arteria morbo. Eur tauri medicamentis Res MCMXCIX, VII, 19-25.
55. Wei, Z., Peng, Quintus; et Lau, B. Pycnogenol endothelial cellulis auget antioxidant defensiones. Redox Report MCMXCVII, III: 219-224.
56. Virgili, P., Kobuchi, H. et Packer, Pinus sylvestris L. Procyanidins expressum iri a maritima (Pycnogenol) scavengers, et ex species modulators nitrogen libero radicitus monoxide metabolismi in activated musculus INCOCTUS macrophages 264.7. Liberum Radic.Biol med MCMXCVIII, XXIV (7-8) 1120-1129. View abstracto.
57. Macrides, C. A., Shihata, A., Kalafatis famulam tuam N., et Wright, F, P radicalis scavenging hydroxyl collatio de proprietatibus atra turpis moleculas V-beta scymnol et pycnogenols plant. Mol Biol Biol Int MCMXCVII, XLII, 1249-1260. View abstracto.
58. Noda, Y., Anzai, K. Mart, A., Kohno, M., Shinmei: M. et Packer, L. hydroxyl anion radicalis scavenging, et superoxide activities of computerized naturalis fons est per facilisis jes-FR30 ESR ratio spectrometer . Mol Biol Biol Int MCMXCVII: XLII: 35-44. View abstracto.
59. Furumura, M., Sato famulam tuam N., Kusaba famulam tuam N., Takagaki, K., et Nakayama, J. Vertebrata Gallica nec nautica pinus mutabit valentes latrare videntes vana et extract (Flavangenol ((R))) In Volume symptoms amplio photoaged facialis cutis. Clin.Interv.Aging MMXII, VII, 275-286. View abstracto.
60. Perera famulam tuam N., Liolitsa, D., Iype, S., Croxford A., Yassin, M., Lang, P., Ukaegbu, O., et frontem ivi ad C. Phlebotonics anorum. Cochrane.Database.Syst.Rev. MMXII: VIII: CD004322. View abstracto.
61. Schoonees, A., Visser, J., Musekiwa: A. et Volmink, J. Pycnogenol (R) (French nec nautica pinus mutabit valentes latrare videntes vana et extract) ad curatio longos perturbationes. Cochrane.Database.Syst.Rev. MMXII: IV: CD008294. View abstracto.
62. Schoonees, A., Visser, J., Musekiwa: A. et Volmink, J. Pycnogenol ((R)) ad curatio longos perturbationes. Cochrane.Database.Syst.Rev. MMXII, II: CD008294. View abstracto.
63. Marini, A., Grether-Beck, S., Jaenicke, T, Weber, M., Burki, C., Formann, P., Brendenus nomine, H., Schonlau, F, et Krutmann, J. Pycnogenol (R ) auctus effectus in cute elasticitas et potus methodis conveniret gene type ego collagen expressions et hyaluronic acidum precursor in mulieribus. Cutis Pharmacol.Physiol MMXII, XXV, 86-92. View abstracto.
64. Mach, J., Midgley, A. W., Dank, S., dona, R. S., and Bentley, In D. J. antioxidant effectus durante exercitium laboris suppletionem est: partes enim potentiale Glutathione S + (H). Nutrimentum. MMX, II: 319-329. View abstracto.
65. Enseleit, P., Sudano: I. Penat, D., Winnik, S., Wolfrum, M., Flammer, Francis, Frohlich, GM, Kaiser, A.: Hirt, A.: Ave, SI, Krasniqi, N ., Quaestionis de Reductione CM, Uhlenhut, K., Hogger, P., Neidhart, M., Luscher, TF, Ruschitzka, F, et Noll, G. de effectibus Pycnogenol endothelial firmum munus in patientibus coronarius arteria morbo, est duplex caecus, randomized, placebo-sobrie, crux, super studium. J. Eur.Heart MMXII: XXXIII: 1589-1597. View abstracto.
66. Luzzi, R., Belcaro, G.: Zulli, C., Cesarone, MR, Cornelli, II, Dugall, M., Hosoi: M. et Feragalli, B. Pycnogenol (R) suppletionem amplio cognitiva munus, et attendere mentis in perficientur alumni. Panminerva Med. MMXI, LIII (Suppl III I): 75-82. View abstracto.
67. Errichi, S., Bottari, A., Belcaro, G.: Cesarone, MR, Hosoi, M., Cornelli, II, Dugall, M., Sparke, A. et Feragalli: cum B. ELOGIUM Pycnogenol (R) Menopausalis signa et symptoms amplio transeuntem. Panminerva Med. MMXI, LIII (Suppl III I): 65-70. View abstracto.
68. Belcaro, G.: Luzzi, R., De Cesinaro, Rocco P. Cesarone, MR, Dugall, M., Feragalli, B., Errichi expriment BM, Ippolito, L., Grossi, MG, Hosoi, M., Errichi , S., Cornelli, II, Sparke, A. et Gizzi, G. Pycnogenol (R) melioramentis in administratione suspirio. Panminerva Med. MMXI, LIII (Suppl III I): 57-64. View abstracto.
69. Errichi expriment BM, Belcaro, G.: Hosoi, M., Cesarone, MR, Dugall, M., Feragalli, B., Bavera, P., Hosoi, M., Zulli, C., Corsi, M., Sparke, A., Luzzi, R. et Ricci, A. Ne post thrombotic cum Pycnogenol syndrome (R) in studio duodecim mensis. Panminerva Med. MMXI, LIII (Suppl III I): 21-27. View abstracto.
70. Appel, B., Nagao, J., Ueda, T., Fortis, JM, Schonlau, P.,-Yu Jing, S., Lu, y et Horie, taxatio S. C. supplemento Pycnogenol (R ) et L-arginine Iaponica in patientibus mitis gloriam temperare, iracundiam Praesent. Phytother.Res. MMXII, XXVI, 204-207. View abstracto.
71. Ohkita, M., Kiso, Y., et Additamenta, V. Materia Medica sani cibos: in emendationem vascularium endothelial munus ab Gallica nec nautica pinus mutabit valentes latrare videntes vana extract (Flavangenol). J.Pharmacol.Sci. MMXI, CXV, 461-465. View abstracto.
72. Dvorakova, M., Paduchova, Z., Muchova, J., Durackova, A., and Collins, R. Ut non pycnogenol A. (R) oxidative potentia et de eo reparando DNA damnum facultatem ad senes populi? Prague.Med.Rep. MMX, CXI, 263-271. View abstracto.
73. Henrotin, V.: Lambertus, C., Couchourel, D., Ripoll, C., et Chiotelli, C. Nutraceuticals: quia constituunt novam aetatem in Ecclesiae administratione OSTEOARTHRITIS? - recensionem ordinare narrationem in quinque capta Lectiones products. Osteoarthritis.Cartilage. MMXI: XIX: 1-21. View abstracto.
74. Pavone, C., Abbadessa, D., Tarantino: L. M., Oxenius, I., lagana, A., Lupo, A. et Rinella, M. [adsumendo Serenoa pubescens, Quercus alba et Pinus pinaster. Salutem et curatio quasdam rationes movendi ad minus ex indicia urinariorum tractu. CCCXX studiis in futurum aegris]. Urologia. MMX, LXXVII, 43-51. View abstracto.
75. Drieling, R. L.: Cicero, C. D., ma, J., AHN, D. E., and Stafford, et pinei corticis conteritur extract R. S. Non expediunt effectus in cardiovasculares morbo periculo factores. Arch.Intern.Med. 9-27-2010: CLXX, 1541-1547. View abstracto.
76. Germar, J., Wolfle, II, Korting, C. H. et Schempp, C. Qui hederam, in qua cutis morbus? Pars II: Dermatophytes, inveterata venarum insufficientiam, photoprotection, Aktinische Arsenhyperkeratosen, vitiligo, capillos damnum, medicamine indiciis. J.Dtsch.Dermatol.Ges. MMX, VIII, 866-873. View abstracto.
77. Grossi, MG, Belcaro, G.: Cesarone, MR, Dugall, M., Hosoi, M., Cacchio, M., Ippolito, E., and Bavera, fluxus et cochleae in Cultura C. Pycnogenol (R) in cum aegris tinnitus, est gubernator iudicium. Panminerva Med. MMX, LII (Suppl I II): 63-67. View abstracto.
78. Senescallus, S., Belcaro, G.: Cesarone, MR, Ricci, A., Dugall, M., Cornelli, II, Gizzi, G., Pellegrini, L. et Rohdewald, PJ munus in metabolicae syndrome potest esse Renibus melius est Pycnogenol (R). Panminerva Med. MMX, LII (Suppl I II): 27-32. View abstracto.
79. Cesarone, M.R., Belcaro, G.: Rohdewald, P., Pellegrini, L., Sparke, A., Vinciguerra, G.: Ricci, A., Ippolito, E., luliae Fanestri conlocavi F. Dugall, M., Cacchio, M., de, Renzo A., Hosoi, M., Senescallus, S., et Corsi, M. Emendationem signa et indicia et microangiopathy cum inveterata venarum insufficientiam Pycnogenol: futurum est, dispensata studiis. Phytomedicine. MMX: XVII: 835-839. View abstracto.
80. Cesarone, MR, Belcaro, G.: Senescallus, S., Schonlau, G., De, Renzo A., Grossi, MG, Dugall, M., Cornelli, II, Cacchio, M., Gizzi, G.: et Pellegrini, L. Renibus fluxus et munus hypertension, tutela effectus est in hypertensive pycnogenol participantium - a regitur studium. J.Cardiovasc.Pharmacol.Ther. MMX, XV, 41-46. View abstracto.
81. Belcaro, G.: Cesarone, MR, Errichi, B., De, Renzo A., Grossi, MG, Ricci, A., Dugall, M., Cornelli, II, Cacchio: M. et Rohdewald P. Pycnogenol curatio acuti hemorrhoidal absolutam. Phytother.Res. MMX, XXIV, 438-444. View abstracto.
82. Steigerwalt, R., Belcaro, G.: Cesarone, MR, DI, Renzo A., Grossi, MG, Ricci, A., Dugall, M., Cacchio: M. et Schonlau, P. Pycnogenol meliorem microcirculation, pede OEDEMA et visivae acutissime in mane diabetic retinopathy. J.Ocul.Pharmacol.Ther. MMIX: XXV: 537-540. View abstracto.
83. Belcaro, G.: Cesarone, M., Silviae, E., Sparke, A., Senescallus, S., GV, Dougall, M., Cornelli, II, Hastings, C., et Schonlau, P. quotidie sumptionem VIII weeks Reliv Glucaffect propter significantly deprimitur sanguinis GLYCOSA et corpus pondus in L subjecta. Phytother.Res. 4-29-2009: View abstracto.
84. Rucklidge, J. J., Johnstone, J. et Kaplan, J. B. Magnesium suppletionem aditus ad curatio de ADHD. Expert.Rev.Neurother. MMIX, IX, 461-476. View abstracto.
85. Zibadi, S., Rohdewald, J. P, Park, D., et Watson, R. R. reductionem in cardiovascular periculo factores type II diabetes furens ira cum Pycnogenol suppletionem. Nutr.Res. MMVIII: XXVIII: 315-320. View abstracto.
86. Belcaro, G.: Cesarone, MR, Errichi, S., Zulli, C., Errichi expriment BM, Vinciguerra, G.: Sparke, A., De Renzo, A., Senescallus, S., Dugall, M., Pellegrini L., Gizzi, G., Ippolito Results for: Ricci, A., Cacchio, M., Cipollone, G., Ruffini, I., luliae Fanestri conlocavi F. Hosoi: M. et Rohdewald P. Aeterna in C-reactivum dapibus, pLASMA liberum radicalis et fibrinogen values ​​in aegris cum OSTEOARTHRITIS Pycnogenol tractata sunt. Redox.Rep. MMVIII: XIII: 271-276. View abstracto.
87. Ryan, J., Croft, K. Mart, T, Wesnes, K., Spong, J., Downey L., Kure, C., Lloyd, J. et Stough: C. An examen ad effectus, ex antioxidant Pycnogenol perficientur in cognitiva, serum lipid profile, et Endocrinological per oxidative accentus biomarkers senes populi. J Psychopharmacol. MMVIII: XXII: 553-562. View abstracto.
88. Cisar, P., Jan, R., Waczulikova, I., Sumegova, K., Muchova, J., Vojtassak, J., Durackova, Z., Lisy: M. et Rohdewald P. effectum conflictus pinei corticis conteritur extract (Pycnogenol) OSTEOARTHRITIS de genu indicia. Phytother.Res. MMVIII, XXII, 1087-1092. View abstracto.
89. Renault famulam tuam N., Uebaba, K., Kohama T. Moniwa famulam tuam N., Kanayama tuarum N. et Koike, nec nautica pinus mutabit Gallico C. valentes latrare videntes vana et analgesic medicamento postulationem extract significantly demittit in dysmenorrhea, et multicenter, randomized, duplex caecus, placebo-sobrie studiis. J Reprod.Med. MMVIII: LIII: 338-346. View abstracto.
90. Belcaro, G.: Cesarone, MR, Errichi, S., Zulli, C., Errichi expriment BM, Vinciguerra, G.: Sparke, A., De Renzo, A., Senescallus, S., Dugall, M., Pellegrini L., Errichi, S., Gizzi, G., Ippolito Results for: Ricci, A., Cacchio, M., Cipollone, G., Ruffini, I., luliae Fanestri conlocavi F. Hosoi, M., Rohdewald P. Pycnogenol Sanatio Osteogenesis imperfecta est. Et SVOS (San-Valentino Osteo Arthrosis Latin). Iudicium et signa docebo, physica perficientur et vascularium facies. Phytother.Res. MMVIII: XXII: 518-523. View abstracto.
91. Dvorakova, M., Jezova, D., Blazicek, P., Trebaticka, J., Skodacek, I., Suba, J., Iveta, W., Rohdewald, P., and Durackova, I. Urinariorum in filios et catecholamines operam defectubus hyperactivity inordinatio (ADHD) modulatio ab polyphenolic pinei corticis extractum a (pycnogenol). Nutr.Neurosci. MMVII: X (3-4): 151-157. View abstracto.
92. Nikolova, V.: Stanislavov, R., Vatev, I., Nalbanski, B., et Punevska, M. [Sperm parametros in masculum infecunditate idiopathica post curatio cum prelox]. Akush.Ginekol. (Sofiia) MMVII: XLVI: 7-12. View abstracto.
93. Cesarone, MR, Belcaro, G.: Rohdewald, P., Pellegrini, L., Sparke, A., Vinciguerra, G.: Ricci, A., Gizzi, G., Ippolito, E., luliae Fanestri conlocavi F. Dugall , M., Acerbi, G.: Cacchio, M., de Renzo, A., Hosoi, M., Senescallus, S., et Corsi, M. celeri de subsidio signa / symptoms microangiopathy cum inveterata venarum pycnogenol; futurum autem , dispensata studiis. Angiológia MMVI, LVII, 569-576. View abstracto.
94. Chovanova, Z., Muchova, J., Sivonova, M., Dvorakova, M., Zitnanova, I., Waczulikova, I., Trebaticka, J., Skodacek, I., et Durackova: I. Effectus polyphenolic extract, Pycnogenol, in VIII-campester of patiens oxoguanine in filios ex operam defectubus / hyperactivity inordinatio. Liberum Radic.Res MMVI, XL, 1003-1010. View abstracto.
95. Dvorakova M. Sivonova M. Trebaticka J. Skodacek, I. Waczulikova, I. Muchova J. et Durackova Z. pinei corticis extractum a polyphenolic effectus, rationeque Pycnogenol Taxus liberis operam defectubus hyperactivity inordinatio pati (ADHD). Redox.Rep. MMVI, XI, 163-172. View abstracto.
96. Vossius, P., Horakova L., Jakstadt, M., Kiekebusch, D., et Gordianus III T. ferritin proteasomal degradation oxidatio et, facilisis a tutela. Liberum Radic.Res MMVI: XL: 673-683. View abstracto.
97. Belcaro, G.: Cesarone, MR, Errichi expriment BM, Sparke, A., De, Renzo A., Senescallus, S., Dugall, M., Pellegrini, L., Gizzi, G.: Rohdewald, P., Ippolito Results for: Ricci, A., Cacchio, M., Cipollone, G., Ruffini, I., luliae Fanestri conlocavi F. Nocte et Hosoi, M. diabetic ulceribus medicinam microcirculatory melius et citius in pycnogenol. Clin.Appl.Thromb.Hemost. MMVI: XII: 318-323. View abstracto.
98. Ahn, J., Grun, I. u, et uni Mustaphae studere, A. Effectus microbial augmentum in herba excerpta, color mutatio, et lipidorum oxidatio in coctum bubulae. Cibus familiaris. MMVII: XXIV: 7-14. View abstracto.
99. Grimm, T., Skrabala, R., Chovanova, Z., Muchova, J., Sumegova, K., Liptakova, A., Durackova, Z., et Hogger P. unius aut plures ex Farmacocinética consectetuer nec nautica pinus mutabit valentes latrare videntes vana extract (pycnogenol) ut administratio sana oris post voluntariorum fuit. BMC.Clin Pharmacol MMVI: VI: IV. View abstracto.
100. Cesarone, MR, Belcaro, G.: Rohdewald, P., Pellegrini, L., Sparke, A., Vinciguerra, G.: Ricci, A., Gizzi, G., Ippolito, E., luliae Fanestri conlocavi F. Dugall , M., Acerbi, G.: Cacchio, M., de Renzo, A., Hosoi, M., Senescallus, S., et Corsi, M. Pycnogenol ac invicem comparatione ageretur Daflon inveterata venarum insufficientiam, in futurum temporibus gubernantur studere. Clin Appl Thromb.Hemost. MMVI: XII: 205-212. View abstracto.
101. Trebaticka, J., Kopasova, S., Hradecna, Z., Cinovsky, K., Skodacek, I., Suba, J., Muchova, J., Zitnanova, I., Waczulikova, I., Rohdewald, P., et Durackova, I. Curatio cum ADHD Gallica nec nautica pinus mutabit extract valentes latrare videntes vana, Pycnogenol. Eur.Child Adolesc.Psychiatry MMVI, XV, 329-335. View abstracto.
102. Chayasirisobhon: S. Usus extract a pinei corticis conteritur et antioxidant Vitamin combination for Lorem productum, sicut CROTAPHOS verterunt ad pharmacologic aegris elit. Capitis MMVI: XLVI: 788-793. View abstracto.
103. Grimm, T., Chovanova, Z., Muchova, J., Sumegova, K., Liptakova, A., Durackova, Z., et Hogger P. falciparum NF-kappaB Matrix-IX orem digestionem per activation et plasma ex hominibus post ingestion de voluntariis mercede nautica pinus mutabit valentes latrare videntes vana extract (Pycnogenol). J Inflamm. (London) MMVI: III: I. View abstracto.
104. Schafer, A., Chovanova, Z., Muchova, J., Sumegova, K., Liptakova, A., Durackova, Z., et Hogger P. falciparum de COX, I-II COX, et actio ex voluntate human plasma Dei post ingestion Gallica nec nautica pinus mutabit valentes latrare videntes vana extract (Pycnogenol). Biomed.Pharmacother. MMVI: LX: 5-9. View abstracto.
105. Belcaro, G.: Cesarone, MR, Errichi expriment BM, Sparke, A., De Renzo, A., Senescallus, S., Dugall, M., Pellegrini, L., Rohdewald, P., Ippolito, L., Ricius , A., Cacchio, M., Ruffini, I., luliae Fanestri conlocavi F. Nocte et Hosoi, M. venarum ulcera, microcirculatory melius et citius loci sanationem in usum Pycnogenol. Angiológia MMV, LVI, 699-705. View abstracto.
106. Renz, ne quid L. photoaging? Obsido J Dermatol. MMV: CXXV: ix-xii. View abstracto.
107. Torras, M. A., faura, C. A., Schonlau, F, et Rohdewald P. Bacillus Pycnogenol ex actione. Res Phytother MMV, XIX: 647-648. View abstracto.
108. Thornfeldt, C. Cosmeceuticals quibus herbae quidem ficta est, et futurum. Dermatol.Surg. MMV, XXXI (VII Pt II): 873-880. View abstracto.
109. Cesarone, MR, Belcaro, G.: Rohdewald, P., Pellegrini, L., Ippolito, E., Scoccianti M. Ricci, A., Dugall, M., Cacchio, M., Ruffini, I., luliae Fanestri conlocavi , P., Acerbi, G.: Vinciguerra, MG, Bavera, A., de Renzo, A., Errichi, BM, Mucci, M. Ne longa volatus in in OEDEMA Pycnogenol. Appl.Thromb.Hemost Clin. MMV, XI, 289-294. View abstracto.
110. Huang, W. W. Yang, S. J., Lin, C. F. Nocte Diei declina paulisper et J. W. et Lee, M. R. Pycnogenol inducit distinctionem, et apoptosis in LX-III leukemia promyeloid humana cellulis. Leuk.Res MMV: XXIX: 685-692. View abstracto.
111. Segger, Schonlau D. and F. ELOGIUM et levitas cutis elasticitas in Evelle improves, duplex caecus, placebo-sobrie studiis LXII cum mulieribus. J Dermatolog.Treat. MMIV: XV: 222-226. View abstracto.
112. Mochizuki, Hasegawa M. et N. Pycnogenol lipolysis incitat, in cellula-L1 3T3 per titillatione beta-receptor actio est mediata. Res Phytother MMIV, XVIII, 1029-1030. View abstracto.
113. Mochizuki, Hasegawa M. et N. medicinales efficaciam pycnogenol in experimentalem ex inflammatione morbo alvum. Res Phytother MMIV, XVIII, 1027-1028. View abstracto.
114. Dene A. B., Maritim, C. A., Sanderus, A. R. et Watkins, J. B., III. De normalis rat curatio diabetic pede et antioxidant effectus enzyme activities. Ibi J Ocul.Pharmacol MMV, XXI, 28-35. View abstracto.
115. Berryman, M. A., Maritim, C. A., Sanderus, A. R. et Watkins, J. B., III. A mures inclusi essent afficiunt curatio diabetic cum combinationibus pycnogenol, beta-carotene, et lipoic acidum, in dulcis alpha oxidative accentus parametri. J Mol Biol Toxicol MMIV: XVIII: 345-352. View abstracto.
116. Cicero, A. B., Lau, H. B., Ide, N., Rong, M. Pycnogenol inhibits macrophage oxidative alioquin rumpuntur utres lipoprotein oxidatio, et hydroxyl radicitus-effecerunt DNA damnum. Dev.Ind medicamento pharm MCMXCVIII, XXIV, 139-144. View abstracto.
117. Kim, S. G., et Park, M. H. Et Pycnogenol in DNA damnum effectus est in vitro et expressio superoxide dismutase HP1 et fallere catalase in Mus CAESPES et mutant cellulis. Phytother.Res MMIV: XVIII: 900-905. View abstracto.
118. Belcaro, G.: Cesarone, MR, Rohdewald P: Ricci, A., Ippolito, E., Dugall, M., Griffin, M., Ruffini, I., Acerbi, G.: Vinciguerra, MG, Bavera, P., de Renzo, A., Errichi, BM, Cerritelli, M. Ne thrombophlebitis et venarum thrombosis in long-bolum volatus sunt pycnogenol. Appl.Thromb.Hemost Clin. MMIV: X: 373-377. View abstracto.
119. , Marsilii Siler, K I., Paiva, M., Madorsky, I., Serrano, Y., Neeley: A. et Heton, B. M. Protective pycnogenol dubie, viae in ethanol praeservatum granulum-contumeliis affecti cerebelli cellulis. J Neurobiol. MMIV: LXI: 267-276. View abstracto.
120. Ahn, J., Grun, I. u, et uni Mustaphae studere, A. Bacillus et anti-oxidant natura desumptis ex vitro bubulae et in terra. Victus J c. MMIV: LXVII, 148-155. View abstracto.
121. Liu X, Wei, J., Tan, P., Zhou, S., Wurthwein, G., et Rohdewald P. Pycnogenol, Gallica nec nautica pinus mutabit extract valentes latrare videntes vana, improves endothelial munus hypertensive aegros. Sci 1-2-2004: LXXIV: 855-862. View abstracto.
122. Zhang, D., Tao, Y., Gao, J., Zhang, C., Wan, S. Chen, Y., Huang XI, Sun, X, Duan, S., Schonlau, P., Rohdewald, P., and Zhao, et liberum radicalis B. Pycnogenol scavenges Filtra sunt in cigarettes toxicity, et reduces Salmonella in vivo Tabaci fumo. Toxicol MMII Salutem India: XVIII: 215-224. View abstracto.
123. Maritim, A., Dene A. B., Sanderus, A. R. et Watkins, J. B., III. In curatio effectus oxidative accentus in streptozotocin pycnogenol ex-diabetic adductus mures inclusi essent. J Mol Biol Toxicol MMIII: XVII: 193-199. View abstracto.
124. Hosseini, S., Pishnamazi, S., Sadrzadeh: S. M., Farid, P., Farid, R. et Watson, R. R. Pycnogenol ((R)) in Management anhelis. Victus J med MMI, IV: 201-209. View abstracto.
125. Sharma, S. C., Sharma, S., et Gulati, OP Pycnogenol vetat obscura in remissionis de histamine malum cellulis. Res Phytother MMIII: XVII: 66-69. View abstracto.
126. Devaraj, S., Vega, Lopez, S., Kaul famulam tuam N., Schonlau, P., Rohdewald, P., and Jialal, dives in polyphenols extractum I. ELOGIUM et pinei corticis conteritur, et crescit plasma antioxidant facultatem uariat plasma lipoprotein profile. Spermatophyta MMII: XXXVII: 931-934. View abstracto.
127. Roseff, munus apud S. J. Cultura in sperma qualitas et arborum cortices extract Gallica nec nautica pinus mutabit. J Reprod med MMII: XLVII: 821-824. View abstracto.
128. NI, Z., mu, y et Gulati Latinitatis Nederlandicae Curatio Melasma cum Pycnogenol. Phytother.Res. MMII: XVI: 567-571. View abstracto.
129. Kimbrough, C., Felix, M., la: G. Roca, et Lau, H. B. PYCNOGENOL rememorando secum cummis, gingival cruentamque, Regium, et TABULA formation. Phytomedicine MMII, IX, 410-413. View abstracto.
130. Peng, L. et Q.: Buz'Zard, A. R. et Lau, B. de H. Pycnogenol protegit neurons amyloideae, precursor beta-adductus apoptosis. Res Res mol cerebrum cerebri 7-15-2002: CIV: 55-65. View abstracto.
131. Cho, S. J., Yun, C. H., Packer, L. et Chung A. S. Plasmodium falciparum dubie, viae bioflavonoids quarta dereptum cortice pinus extractum a maritima expressio proinflammatory cytokines. Ann N ego Acad Sci MMI, CMXXVIII: 141-156. View abstracto.
132. Kim: C. et H. Healey, J. M. Effecta pinei corticis conteritur extract administratum est immunosuppressed infectas similitudines murium, cum adulta Cryptosporidium parvum. J Chin med MMI, XXIX (3-4): 469-475. View abstracto.
133. Stefanescu, M., Matache, C., ONU, A., Tanaseanu, S., Dragomir, C., m Constantinescu, I., Schonlau, P., Rohdewald, P., and Szegli, G. Pycnogenol quasdam rationes movendi ad curatio ex systemic lupus erythematosus aegris. Res Phytother MMI, XV, 698-704. View abstracto.
134. Cho, draconem, Yun, CH, poniturque Yoon, DY, cho, YS, Rimbach, G., Packer, L. et Chung, ut effectus ex quarta dereptum cortice pinus extractum bioflavonoids maritima in proinflammatory cytokine interleukin I-in productionem lipopolysaccharide- NOVICIUS incitemur: 264.7. Toxicol 10-1-2000 Appl.Pharmacol, CLXVIII, 64-71. View abstracto.
135. Huynh, H., et S. Teel, R. W. electionem selectivam inductione apud hominum apoptosis mammae cancer cellulis (MCF-VII) by pycnogenol. Res Anticancer MM: XX: 2417-2420. View abstracto.
136. Peng, Q., Wei: I. et Lau, H. B. Pycnogenol inhibits Tumor necrosis factor alpha-effecerunt activation and B Kappa nuclei factor in humanae expressio ubertatem acciperet moleculo vascularium endothelial cellulis. Mol Cell In Sci MM, LVII, 834-841. View abstracto.
137. Araghi, Niknam, M., Hosseini, S., Larson, D., Rohdewald, P., and mi Watson, R. R. pinei corticis conteritur extract reduces platelet aggregatio. Integr.Med. 3-21-2000, II, 73-77. View abstracto.
138. Moini, H., Arroyo: A., Vaya, J. et Packer, L. effectus bioflavonoid in torquem turpis electronic resource mitochondrial respiratoriorum et Cytochrome redox status c. MCMXCIX Redox.Rep: IV (1-2): 35-41. View abstracto.
139. Bors, W., Michel, C., et Stettmaier, K Gramineae resonans paramagnetico studiis radicitus de speciebus et de albumin proanthocyanidins esters. Arcus Biol Biophys. 2-15-2000, CCCLXXIV: 347-355. View abstracto.
140. Kobayashi, M. S. Han, D., et Packer, herbal excerpta L. Facilisis ac defendat adversus glutamate neuronal cells HT-IV-adductus cytotoxicity. Liberum Radic.Res MM: XXXII: 115-124. View abstracto.
141. Hasegawa tuarum N. et Herpesvirus hominis a pycnogenol lipolysis. Res Phytother MCMXCIX: XIII: 619-620. View abstracto.
142. Packer, L., Rimbach, G., et Virgili, P. Antioxidant-dives procyanidin extract de actione et de proprietatibus biologic (Pinus maritima) valentes latrare videntes vana, pycnogenol. MCMXCIX liberum Radic.Biol med: XXVII (5-6): 704-724. View abstracto.
143. Huynh, H., et S. Teel, R. W. de effectibus intragastrically administratum Pycnogenol NNK metabolismi in F344 mures inclusi essent. Res Anticancer MCMXCIX, XIX (3a) 2095-2099. View abstracto.
144. Huynh, H., et S. Teel, R. W. de effectibus pycnogenol microsomal metabolismi de tobacco specifica nitrosamine NNK tamquam munus aetatem. Litterae apostolicae cancer 10-23-1998; CXXXII (1-2): 135-139. View abstracto.
145. Belcaro, G.: Cesarone, MR, Dugall, M., Hosoi, M., Ippolito, E., Bavera, P., and Grossi, ex investigatione Pycnogenol Tabulettae (R) coenzymeQ10 in cumulative cum cor defectum aegros (II NYHA / III). Panminerva med MMX, LII (Suppl I II): 21-25. View abstracto.
146. Clark, C. £, Ambrosius Aurelius Theodosius, E., Lasserson, J. J. Wu, J. interventus eget vetustati suspiriosis in filii et adultis: systematicam review et meta-analysis. Prim.Care Respir.J MMX: XIX: 307-314. View abstracto.
147. Steigerwalt, R. D.: Ioannes, B. Paulo, M., Bombardelli, E., Burki: C. et Schonlau, M. Effecta Mirtogenol et effundatur sanguis in intraocular oculi hypertension in asymptomatic subjecta. Vis mol MMVIII, XIV, 1288-1292. View abstracto.
148. Sparke, A., Belcaro, G.: Cesarone, MR, Dugall, M. et Schonlau, F. de investigatione universa plant extract mansuetum esse ad moderari Praesent in randomized, duplex caecus, placebo-sobrie, parallel- arma studio. BJU.Int. MMX, CVI, 1030-1033. View abstracto.
149. Stanislavov, R., Nikolova, V., et Rohdewald P. Emendationem Prelox semen parametri est: a randomized, duplex caecus, placebo-sobrie, crux, super iudicium. Phytother.Res MMIX: XXIII: 297-302. View abstracto.
150. Wilson D, Evans M, N Porphyrio et al. A randomized, duplex caecus, placebo-sobrie studiis exploratory pycnogenol potentiale ad meliorem aestimare quanti signa allergic RHINITIS. Res Phytother MMX: XXIV: 1115-9. View abstracto.
151. Belcaro G, Cesarone MR A Ricci, et al. Imperium OEDEMA in hypertensive agitur cum calce insit, parem (nifedipine)-convertens enzyme inhibitors aut angiotensin sunt pycnogenol. Clin Appl Thromb Hemost MMVI: XII: 440-4. View abstracto.
152. Vinciguerra G, Belcaro G, Cesarone MR; et al. Et musculorum Cramps dolor: ne cum normalis res in Pyconogenol venosas aegris, athletae, et claudicants diabetic microangiopathy. Angiológia MMVI, LVII, 331-9. View abstracto.
153. Cesarone MR, Belcaro G, Rohdewald P, et al. Melius est diabetic microangiopathy Pycnogenol: A futurum, dispensata studiis. Angiológia MMVI, LVII, 431-6. View abstracto.
154. Liu X, Wei J, Tan F; et al. Antidiabetic modum ex Gallico Pycnogenol nec nautica pinus mutabit valentes latrare videntes vana extract in patientibus diabete type II. Sci MMIV, LXXV, 2505-13. View abstracto.
155. Liu X, Zhou HJ, Rohdewald P.Gallica nec nautica pinus mutabit valentes latrare videntes vana extract pycnogenol adhaereret plenus dose GLYCOSA type II diabetic aegros (litterae). DIABETES Cura MMIV: XXVII: DCCCXXXIX. View abstracto.
156. Kohama T, N Suzuki; Ohno S, M. Inoue Analgesic efficacia, Gallica nec nautica pinus mutabit extract in dysmenorrhea valentes latrare videntes vana, et aperta iudicium orci. J Reprod med MMIV: XLIX: 828-32. View abstracto.
157. Kohama T, M. Inoue Pycnogenol alleviet dolore consociata cum pariendi statutum videretur. Res Phytother MMVI: XX: 232-4. View abstracto.
158. Blazso G, M Gabor, Schonlau F, P. Rohdewald Pycnogenol et reduces vulnus sanitatem, cicatrix accelerat effusos pugnantes. Res Phytother MMIV: XVIII: 579-81. View abstracto.
159. Yang HM non ad recYilineum MF Liao, Zhu SY, et al. A randomized, duplex caecus, placebo-sobrie iudicium ad effectum in Domini super quam climacteras appellant Pycnogenol syndrome In peri-menopausal women. Acta Obstet Gynecol Seand MMVII, LXXXVI, 978-85. View abstracto.
160. Lau BH fefe Riesen SK, Truong KP, et al. Quod est procuratio ex adjunct Pycnogenol in pueritia suspiriosis. J asthma MMIV, XLI, 825-32. View abstracto.
161. Cesarone MR, Belcaro G, Nicolaides AN; et al. Ne venarum thrombosis in long-bolum volatus sunt Flite Est Tabs: A randomized LONFLIT, Flite, sobrie iudicium. Angiológia MMIII: LIV: 531-9. View abstracto.
162. Durackova Z, B Trebaticky, V Novotny, et al. Et per lipidorum metabolismi erectile munus melius Pycnogenol, extract de cortice gluten Pinus pinaster in aegris passus a Praesent in-gubernatori studium. Res Nutr MMIII: XXIII: 1189-98 ..
163. Stanislavov R: V. Nikolova Curatio Praesent pycnogenol et cum L-arginine. Ibi J IUGALIS Sex MMIII: XXIX: 207-13 .. View abstracto.
164. Hosseini S: J Lee, Sepulveda RT, et al. A randomized, duplex caecus, placebo-sobrie, futurum, XVI septem crossover studium ad determinare munus moderandi de pycnogenol in sanguinem pressura in hypertensive aegros, corrigantur. Res Nutr MMI: XXI: 1251-60.
165. Bito T, S Saint, inter Sen CK, Packer L. extract pycnogenol downregulates IFN pinei corticis conteritur, gamma-T cellulis adductus adhaesionem hominis ad keratinocytes a Inhibito inducible I-icam expressio. Liberum radic Mol Biol MM: XXVIII: 219-27 .. View abstracto.
166. Virgili F, G antiqua, Bourne L, et al. Acidum consummatio Ferulic excretion in titulo de Gallicus Maritime Pine (Pinus maritima) Fruit Extract. Liberum radic Mol Biol MM: XXVIII: 1249-56 .. View abstracto.
167. Tenenbaum S, Paul C.: Carmina Burana Passer, et al. An experimentum autem collatio Pycnogenol methylphenidate in adultis, et attentiori studio lectionem facere, Deficit / Hyperactivity Disorder (ADHD). J pertractata notaverunt, Disord MMII: VI: 49-60 .. View abstracto.
168. Plasmodium falciparum Hasegawa de N. per lipogenesis pycnogenol. Res Phytother MM: XIV: 472-3. View abstracto.
169. Liu F BHS Lau, Peng Q. V. mercatorum Pycnogenol tueri vascularium endothelial cellulis a beta amyloideo effecerunt iniuriam. Gen pharm MM tauri: XXIII: 735-7. View abstracto.
170. Virgili F, D Kim, Packer expressum iri a L. Procyanidins pinei corticis conteritur protegat Alpha tocopherol-endothelial cellulis per provocantibusque ECV CCCIV per macrophages 264.7 activated NOVICIUS: partes nitric cadmiae et peroxynitrite. Letters FEBS MCMXCVIII, CDXXXI: 315-8. View abstracto.
171. Park ad YC, Rimbach G, C Saliou, et al. Operatio autem monomeric, dimeric et trimeric productio in flavonoids, TNF alfa-excremento, dependens gene expressio & NF-cruda-GB macrophages 264.7. Letters FEBS MM: CDLXV, 93-7. View abstracto.
172. Saliou C, G Rimbach, Molni H. Et Imago I, S Hosseini, Lee J; et al. Ultraviolet solaris ERYTHEMA, adductus est in hominis cute et nuclei Kappa-factor-b-dependens gene expressio keratinocytes in modulatus editur extract a Gallica nec nautica pinus mutabit valentes latrare videntes vana. Liberum radic Mol Biol MMI: XXX: 154-60. View abstracto.
173. Cheshier Ioram, Ardestani Kaboudanian-S, B Liang, et al. Mammalia, fed per pycnogenol ethanol in murium aut Retrovirus effecerunt. Sci MCMXCVI, LVIII, 87-96. View abstracto.
174. Jialal Ego Devaraj S: Hirany S, et al. Quod autem effectus pycnogenol suppletionem limites figunt, ad inflammationes moveat. MMI alternative therapies: VII: S17.
175. R. Phaseolus vulgaris L. Koch de venostatin in pycnogenol et inveterata venarum insufficientiam. Res Phytother MMII: XVI: S1-S5. Res Phytother MMII: XVI: S1-S5. View abstracto.
176. Magis Zephyrus quam Auster Heiman. Quia Pycnogenol ADHD? Ego sum Panis ACADEMIAE Adolesc Psychiatry MCMXCIX: XXXVIII: 357-8. View abstracto.
177. Ohnishi ST Ohnishi T, Ogunmola GB. Falcem cell anemia, a nutritionis aditumque habet potentiale hypotheticum morbo. MM nutritionem: XVI: 330-8. View abstracto.
178. Mensink Reverendus Katan MB. An experimentum epidemiological studiis per effectum et oleum unctionis fundes super totalis de HDL cholesterol in serum et sanam omnium voluntariorum fuit. Clin J Nutr MCMLXXXIX, Suppl XLIII II: 43-8. View abstracto.
179. Putter M, Grotemeyer proportionales KH, HE Wurthwein G, et al. Aspirin et inhibitionis nibh aggregatione pycnogenol antiplatelet effecerunt. Res Thromb MCMXCIX, XCV, 155-61. View abstracto.
180. A Dauer, Metzner P, O Schimmer Hamamelis virginiana proanthocyanidins de cortice gluten exhibere antimutagenic proprietatibus nitroaromatic in suis Revolutionibus componit. Planta Med MCMXCVIII: LXIV: 324-7. View abstracto.
181. FF docendum, Ludwig, C. Rohdewald Endothelium-effectus dependens ab Pycnogenol vascularis insigniverint. J Cardiovasc Pharmacol MCMXCVIII: XXXII: 509-15. View abstracto.
182. Liu Thomas, Zhang YX, Lau BH. Lucius annaeus seneca, in immune et munera adducunt Pycnogenol haemopoietic accelerated mures inclusi essent. Mol Cell In Sci MCMXCVIII, LIV, 1168-72. View abstracto.
183. Definition | JM Tixier, et al. Quod per in vitro et in vivo studies of binding pycnogenols quod elastin eius pertinet ad rate of per degradation elastases. Biol Pharmacol MCMLXXXIV, XXXIII, 3933-9. View abstracto.
184. Roseff SI, R. Gulati Emendationem sperma qualitas per pycnogenol. Eur medicamentis Res MCMXCIX tauri: VII: 33-6.
185. T Kohama, Suzuki N. et curatio gynecological cum pycnogenol perturbationes. Eur medicamentis Res MCMXCIX tauri: VII: 30-2.
186. C. Melior Pavlovic patientia in usum facilisis. Eur medicamentis Res MCMXCIX tauri: VII: 26-9.
187. Wang S, Tan D, Zhao ego, et al. Quod autem effectus in pycnogenol microcirculation, platelet et ischemic myocardium munus in patientibus coronarius arteria morbo. Eur tauri medicamentis Res MCMXCIX, VII, 19-25.
188. C. Redigo Rohdewald periculo ictu et cor tuum quia ex pycnogenol INFARCTUS. Eur tauri medicamentis Res MCMXCIX, VII, 14-18.
189. Gulati OP. Pycnogenol in venarum perturbationes: A recenseo. Eur medicamentis Res MCMXCIX tauri: VII: 8-13.
190. P. Rohdewald Biodisponibilidad pycnogenol et metabolismi. Eur tauri medicamentis Res MCMXCIX, VII, 5-7.
191. Hunt Christum Dominum nostrum. Reductionem in periculo res a cardiovascular morbus Gallica nec nautica pinus mutabit valentes latrare videntes vana extract. CVR MCMXCIX & R: Iunii, 326-9.
192. Spadea L, M. Balestrazzi amet vascularium retinopathies cum pycnogenol. Res Phytother MMI: XV: 219-23. View abstracto.
193. Schmidtke Ego vereor condiscipulorum ne W. Pycnogenol: atque habitus medicinae curatio OEDEMA. Schweizerische Zeitschriftfur GanzheitsMedizin MCMXCV, III, 114-5.
194. Petrassi C, A Mastromarino, Spartera C. Pycnogenol apud inveterata venarum insufficientiam. Phytomedicine MM: VII: 383-8. View abstracto.
195. P. Arcangeli Pycnogenol apud inveterata venarum insufficientiam. Fitoterapia MM; LXXI, 236-44. View abstracto.
196. CA Evans-rice, Packer L., eds. Flavonoids In Salutem et Morbus. Manhattan, NY: Marcel Dekker, Inc., MCMXCVIII.
197. Dominus Packer: Midori n, N Toshikazu, Eds. Antioxidant Food Supplements Humanum In Salutem. San Diego: Nabu Press, MCMXCIX.
198. Crassus Duweler K, P Rohdewald Urinariorum tenuissimum, Gallica nec nautica pinus mutabit valentes latrare videntes vana extract apud homines. Pharmazie MM, LV, 364-8. View abstracto.
199. Nutritius S: Tacitus VE versatur. Bonae 's Herbal Tacitus, 4th ed., Binghamton, NY: Haworth eget Press, MCMXCIX.
200. Skyrme-Jones, Magistrum R. O Brien, Berry ipfarum KL, MNb Meredith 'IT. E Vitaminum suppletionem amplio endothelial munus In typus ego diabete Mellitus: a randomized, placebo-sobrie studiis. J AM Coll Cardiol MM: XXXVI: 94-102. View abstracto.
201. JJ J Corrigan Jr. Bacteria difficultates quae in Vitaminum E. Pediatr Hematol Oncol MCMLXXIX, I, 169-73. View abstracto.
202. Branchey L, M Branchey, Shaw S, Lieber CS. Mutationes in necessitudinem inter amino acida plasma atque tristitia in aegris bibitor. J am Psychiatry MCMLXXXIV, CXLI, 1212-5. View abstracto.
203. Instituti de Medicina. Et dapibus et amino acida sustinent partes perficientur et enhancing. Washington, DC: National Museum Press, 1999. Available at: http://books.nap.edu/books/0309063469/html/309.html#pagetop
204. Newall CA, O Anderson, Philpson JD. Herbal Medicine: A nam Healthcare Professionals. London, UK: De pharmaceutical Press, MCMXCVI.
205. Tacitus VE versatur. Arbitrio herbis. Binghamton, NY: Pharmaceutical Products Press, MCMXCIV.
206. Blumenthal M, ed. Latin German Edition Commission E: therapeutica Rector ut Donec medicinam. Trans. S. Klein. Boston, MA: National American Consilii, MCMXCVIII.

From Review - 10/02/2020